Your automated
disinfection technology.
Brought to you by
The only patented,hospital-grade
surface disinfecting system approved for fogging
EPA-registered Hypochlorous acid (HOCl).
Reaches 100% of surfaces and room air
Immediate room re-entry
ZERO pathogen transfer and human variability
Delivers LOG 4-6 EPA registered efficacy
Cloud-based data and reporting
Technology
The New Evolution of Whole Room Disinfection.
Ultra-fine HOCl atomization (fogging) technology
Ensures 100% room surface and air contact
No shadowing
Automated Technology
Hands free with no monitoring or repositioning
Eliminates pathogen transfer
Dehumidification and air scrubbing technology
Rapidly removes fog and moisture from room
Safe for immediate room re-entry
Nevoa’s proprietary
Hypochlorous Acid solution
No Shelf life due to patented mixing cap
pH neutral – less corrosive than bleach
Environmentally safe and responsible
Bar-coded for quality control and data tracking
FDA considers HOCl to be:
“…the form of free available chlorine having the highest bactericidal activity against a broad range of microorganisms…” U.S.FDA,2015
Greater than
against pathogens
on surfaces and room air.
Independent Study Results
Staphylococcus aureus
Gram-positive bacteria.
Tested with soil load,
ATCC #6538.
Average results:
6.5 Log10 reduction
Pseudomonas aeruginosa
Gram-negative bacteria
(MDRO).Tested with soil
load, ATCC #15442.
Average results:
6.5 Log10 reduction
Influenza A
Enveloped virus.
Tested with soil load,
10 min. contact,
ATCC #VR-1469.
Average results:
4.8 Log10 reduction
Vancomycin-resistant ebericiccys
(VRE) enerococcus faecalis
Gram-positive bacteria (MDRO).
Tested without soil load,
ATCC #51575.
Average results:
5.6 Log10 reduction
Human Rhinovirus
Non-enveloped virus. Tested
with soil load,1 min. contact,
ATCC #VR-283,
Strain 11757.
Average results:
4.8 Log10 reduction
Norovirus
Non-enveloped virus, EPA
recognized surrogate for Human Norovirus. Tested with soil
load,1 min. contact,
ATCC #VR-782,Strain F-9.
Average results:
5.2 Log10 reduction
Salmonella enterica
Gram-negative bacteria.
Tested with soil load,
ATCC #10708.
Average results:
6.4 Log10 reduction
Methicilin - resistant
Staphylococcus aureus MRSA
Gram-positive bacteria (MDRO).
Tested with and without soil
load, ATCC #33592.
Average results:
4.8 Log10 reduction
Hover to see study results
Escherichia coli
Gram-negative bacteria.
Tested without soil load,
ATCC #15597.
Average results:
4.0 Log10 reduction
Candida auris
Fungus (MDRO) identified in
2009.Tested with soil load,
2 min. contact,CDC Strain
B11903.
Average results:
4.8 Log10 reduction
Clostridium difficile
Gram-positive bacterial
spore (MDRO). Tested against spores with soil load, 10 min. contact,
ATCC #43598.
Average results:
5.9 Log10 reduction
EPA Registered
Hospital Grade Disinfection
EPA Protocol
The EPA protocol for fogging device testing states that target(test) microorganisms must be placed in 20 different locations within the room (ceilings, walls, floors, under tables, etc.) to ensure the disinfectant is reaching ALL surfaces and is at least 99.99% effective at all locations.
EPA registration as a hospital-grade disinfectant required antimicrobial performance testing against
three primary microorganisms: S. aureus, S. enterica,
and P. aeruginosa. These three microorganisms were tested at each of the 20 room locations in triplicate
for a total of 180 total in-vitro samples.
Our nimbus achieves
disinfection than manual
cleaning alone.
Reynolds K: Critical Care Explorations. February 2021,
Volume 3, Number 2
300X better disinfection than manual cleaning alone
64% less labor for terminal cleaning
Zero pathogen transfer
30-minutes of labor gained for reallocation
Efficiencies Gained
Request a live demo from a product specialist!
Our Mission Is Clear
Nevoa was created to tackle a major problem that
few outside of the healthcare environment are
aware of. Healthcare Acquired Infections (HAIs) are
the 5th leading cause of death in the United States.
One out of 25 patients get an infection they didn’t
have when they were admitted to a hospital.HAIs
cause up to 100,000 deaths and exceed $45 Billion
in direct medical cost each year. Despite the
incredible efforts taken by hospital teams, these infections continue to be a problem. Nevoa believes
the answer is technology based solutions that
automate disinfection. Nevoa’s mission is to
transform the healthcare industry’s decades-old
manual disinfection and cleaning practices to
highly effective, automated protocols that provide superior disinfection at a reduced overall cost.
While other “whole room” disinfection technologies exist, they all come with significant shortcomings.
Some cannot sufficiently reach pathogens on every surface in a room – including difficult corners or behind and underneath furniture and equipment.
Other options use much more corrosive chemicals
that also require hours before you can safely
re-enter the room.The combination of the Nimbus Technology with Microburst Solution effectively
tackles the issue of HAIs while addressing the short comings of other whole-room disinfection
technologies.
Nevoa
Leadership
Team
The Nevoa leadership team brings decades of experience
from a diverse array of backgrounds.Together they have
created a culture that encourages ideas, inspires passion,
and rewards hard work.They know that Nevoa brings a much needed and technologically advanced solution that will improve the lives of millions.
